Share-based Payment Arrangement, Noncash Expense of Edesa Biotech, Inc. from 31 Aug 2012 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of noncash expense for share-based payment arrangement.
- Summary
-
Edesa Biotech, Inc. quarterly and annual Share-based Payment Arrangement, Noncash Expense in USD history and change rate from 31 Aug 2012 to 31 Dec 2025.
- Edesa Biotech, Inc. Share-based Payment Arrangement, Noncash Expense for the quarter ending 31 Dec 2025 was $399,862, a 393% increase year-over-year.
- Edesa Biotech, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2025 was $729,642, a 36% increase from 2024.
- Edesa Biotech, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2024 was $537,492, a 57% decline from 2023.
- Edesa Biotech, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2023 was $1,246,457, a 45% decline from 2022.
- Source SEC data
- View on sec.gov
Share-based Payment Arrangement, Noncash Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Noncash Expense, Quarterly (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Noncash Expense, Annual (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Annual Change (%)
Edesa Biotech, Inc. Quarterly Share-based Payment Arrangement, Noncash Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $399,862 | +$318,679 | +393% | 01 Oct 2025 | 31 Dec 2025 | 10-Q | 13 Feb 2026 | 2026 | Q1 | |
| Q4 2024 | $81,183 | -$103,174 | -56% | 01 Oct 2024 | 31 Dec 2024 | 10-Q | 13 Feb 2026 | 2026 | Q1 | |
| Q1 2024 | $959,288 | $149,696 | -$137,851 | -48% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 10 May 2024 | 2024 | Q2 |
| Q4 2023 | $1,097,139 | $184,357 | -$149,318 | -45% | 01 Oct 2023 | 31 Dec 2023 | 10-Q | 14 Feb 2025 | 2025 | Q1 |
| Q3 2023 | $1,246,457 | $517,076 | +$61,112 | +13% | 01 Jul 2023 | 30 Sep 2023 | 10-K | 13 Dec 2024 | 2024 | FY |
| Q2 2023 | $1,185,345 | $108,159 | -$457,225 | -81% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 09 Aug 2023 | 2023 | Q3 |
| Q1 2023 | $1,642,570 | $287,547 | -$342,461 | -54% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 10 May 2024 | 2024 | Q2 |
| Q4 2022 | $1,985,031 | $333,675 | -$275,603 | -45% | 01 Oct 2022 | 31 Dec 2022 | 10-Q | 09 Feb 2024 | 2024 | Q1 |
| Q3 2022 | $2,260,634 | $455,964 | 01 Jul 2022 | 30 Sep 2022 | 10-K | 15 Dec 2023 | 2023 | FY | ||
| Q2 2022 | $565,384 | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 09 Aug 2023 | 2023 | Q3 | |||
| Q1 2022 | $630,008 | +$162,569 | +35% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 11 May 2023 | 2023 | Q2 | |
| Q4 2021 | $609,278 | -$113,631 | -16% | 01 Oct 2021 | 31 Dec 2021 | 10-Q | 10 Feb 2023 | 2023 | Q1 | |
| Q1 2021 | $1,399,932 | $467,439 | +$87,439 | +23% | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 14 May 2021 | 2021 | Q2 |
| Q4 2020 | $1,312,493 | $722,909 | +$714,134 | +8138% | 01 Oct 2020 | 31 Dec 2020 | 10-Q | 14 Feb 2022 | 2022 | Q1 |
| Q3 2020 | $598,359 | $198,164 | 01 Jul 2020 | 30 Sep 2020 | 10-K | 28 Dec 2021 | 2021 | FY | ||
| Q2 2020 | $11,420 | -$111,771 | -91% | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 12 Aug 2020 | 2020 | Q3 | |
| Q1 2020 | $380,000 | +$366,554 | +2726% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 14 May 2021 | 2021 | Q2 | |
| Q4 2019 | $8,775 | -$2,659 | -23% | 01 Oct 2019 | 31 Dec 2019 | 10-Q | 16 Feb 2021 | 2021 | Q1 | |
| Q2 2019 | $123,191 | +$100,191 | +436% | 01 Apr 2019 | 30 Jun 2019 | 10-Q | 12 Aug 2020 | 2020 | Q3 | |
| Q1 2019 | $13,446 | 01 Jan 2019 | 31 Mar 2019 | 10-Q | 15 May 2020 | 2020 | Q2 | |||
| Q4 2018 | $11,434 | -$9,272 | -45% | 01 Oct 2018 | 31 Dec 2018 | 10-Q | 13 Feb 2020 | 2020 | Q1 | |
| Q2 2018 | $23,000 | 01 Apr 2018 | 30 Jun 2018 | 10-Q | 14 Aug 2019 | 2019 | Q2 | |||
| Q4 2017 | $20,706 | -$15,736 | -43% | 01 Oct 2017 | 31 Dec 2017 | 10-Q | 05 Feb 2019 | 2019 | Q1 | |
| Q4 2016 | $36,442 | -$88,054 | -71% | 01 Oct 2016 | 31 Dec 2016 | 10-Q | 07 Feb 2018 | 2018 | Q1 | |
| Q4 2015 | $124,496 | +$37,631 | +43% | 01 Oct 2015 | 31 Dec 2015 | 10-Q | 06 Feb 2017 | 2017 | Q1 | |
| Q4 2014 | $86,865 | -$381,852 | -81% | 01 Oct 2014 | 31 Dec 2014 | 10-Q | 08 Feb 2016 | 2016 | Q1 | |
| Q3 2014 | $36,509 | 01 Sep 2014 | 30 Sep 2014 | 10-K | 14 Dec 2016 | 2016 | FY | |||
| Q4 2013 | $468,717 | 01 Oct 2013 | 31 Dec 2013 | 10-Q | 09 Feb 2015 | 2015 | Q1 |
Edesa Biotech, Inc. Annual Share-based Payment Arrangement, Noncash Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $729,642 | +$192,150 | +36% | 01 Oct 2024 | 30 Sep 2025 | 10-K | 12 Dec 2025 | 2025 | FY |
| 2024 | $537,492 | -$708,965 | -57% | 01 Oct 2023 | 30 Sep 2024 | 10-K | 12 Dec 2025 | 2025 | FY |
| 2023 | $1,246,457 | -$1,014,177 | -45% | 01 Oct 2022 | 30 Sep 2023 | 10-K | 13 Dec 2024 | 2024 | FY |
| 2022 | $2,260,634 | -$934,835 | -29% | 01 Oct 2021 | 30 Sep 2022 | 10-K | 15 Dec 2023 | 2023 | FY |
| 2021 | $3,195,469 | +$2,597,110 | +434% | 01 Oct 2020 | 30 Sep 2021 | 10-K | 16 Dec 2022 | 2022 | FY |
| 2020 | $598,359 | 01 Oct 2019 | 30 Sep 2020 | 10-K | 28 Dec 2021 | 2021 | FY | ||
| 2018 | $81,344 | -$34,202 | -30% | 01 Jan 2018 | 31 Dec 2018 | 10-KT | 12 Dec 2019 | 2019 | FY |
| 2017 | $115,546 | -$143,833 | -55% | 01 Oct 2016 | 30 Sep 2017 | 10-K | 30 Nov 2018 | 2018 | FY |
| 2016 | $259,379 | -$7,843 | -2.9% | 01 Oct 2015 | 30 Sep 2016 | 10-K | 01 Dec 2017 | 2017 | FY |
| 2015 | $267,222 | -$689,412 | -72% | 01 Oct 2014 | 30 Sep 2015 | 10-K | 01 Dec 2017 | 2017 | FY |
| 2014 | $956,634 | +$170,049 | +22% | 01 Sep 2013 | 31 Aug 2014 | 10-K | 14 Dec 2016 | 2016 | FY |
| 2013 | $786,585 | -$1,136,615 | -59% | 01 Sep 2012 | 31 Aug 2013 | 10-K | 14 Dec 2015 | 2015 | FY |
| 2012 | $1,923,200 | 01 Sep 2011 | 31 Aug 2012 | 10-K | 21 Nov 2014 | 2014 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.